The bill — S. 296: Preserving Access to Life Saving Medication Act — was introduced by Sen. Amy Klobuchar (D-MN). If passed, it would provide the FDA with tools to better manage and prevent shortages of critical medications, according to the ASCA. It would also increase the FDA’s ability to monitor drugs that are vulnerable to shortages and enable the FDA to establish contingency plans in the event of manufacturing interruptions.
The ASCA sent a letter to Sen. Klobuchar stressing the negative implications of drug shortages on an ASC’s operations and ability to perform procedures. The ASCA is asking surgery centers to contact their members of Congress and urge them to support the legislation.
Learn more about the bill and the ASCA’s support of it by clicking here.
Read more on anesthesia:
– Anesthesiologist-Turned-Governor Declines Government-Subsidized Health Insurance
– Boston Medical Center Anesthesiologist Receives WHO Commendation for Pulse Oximetry Training Video
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
